An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression - Contacts and Locations

An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression

This study has been completed.

Study NCT00146523. Last updated on February 22, 2007. Information provided by Corcept Therapeutics

Please refer to this study by its ClinicalTrials.gov identifier: NCT00146523

Locations


Bulgaria
	Svetlozar H Haralanov Ph.D.
	Sofia, Bulgaria
	Luchezar G Hranov M.D.
	Sofia, Bulgaria
	Georgy Koychev M.D.
	Sofia, Bulgaria
	Georgi Popov M.D.
	Varna, Bulgaria
	Vihra Milanova M.D.
	Sofia, Bulgaria

Croatia
	Goran Dodig M.D./Ph.D.
	Split, Croatia
	Pavo Filakovic M.D./Ph.D.
	Osijek, Croatia
	Vera Folnegovic-Smalc M.D./Ph.D.
	Zagreb, Croatia
	Miro Jakovljevic M.D.
	Zagreb, Croatia
	Ljiljana Moro M.D./Ph.D.
	Rijeka, Croatia
	Dubravka Kocijan-Hercigonja M.D.
	Zagreb, Croatia

Romania
	Aurel Nirestean M.D./Ph.D.
	Targu Mures, Romania
	Mihai Dumitru Gheorge
	Bucharest, Romania

Serbia and Montenegro
	Vladimir Diligenski M.D.
	Belgrade, Serbia and Montenegro
	Jelena Martinovic M.D.
	Belgrade, Serbia and Montenegro
	Ratomir Lisulov M.D.
	Novi Sad, Serbia and Montenegro
	Vladimir Paunovic M.D.
	Belgrade, Serbia and Montenegro
	Ivana Timotijevic M.D.
	Belgrade, Serbia and Montenegro
	Dragana Ignjatovic-Ristic M.D.
	Kragujevac, Serbia and Montenegro

Sponsors and Collaborators

Corcept Therapeutics

Investigators


Study Director:	Katherine Beebe, PhD	Corcept Therapeutics